Vascular anomalies represent a spectrum of disorders from a simple “birthmark” to life- threatening entities. Incorrect nomenclature and misdiagnoses are commonly experienced by patients with these anomalies. Accurate diagnosis is crucial for appropriate evaluation and management, often requiring multidisciplinary specialists. Classification schemes provide a consistent terminology and serve as a guide for pathologists, clinicians, and researchers. One of the goals of the International Society for the Study of Vascular Anomalies (ISSVA) is to achieve a uniform classification. The last classification (1997) stratified vascular lesions into vascular malformations and proliferative vascular lesions (tumors). However, additional disease entities have since been identified that are complex and less easily classified by generic headings, such as capillary malformation, venous malformation, lymphatic malformation, etc. We hereby present the updated official ISSVA classification of vascular anomalies. The general biological scheme of the classification is retained. The section on tumors has been expanded and lists the main recognized vascular tumors, classified as benign, locally aggressive or borderline, and malignant. A list of well-defined diseases is included under each generic heading in the “Simple Vascular Malformations” section. A short definition is added for eponyms. Two new sections were created: one dealing with the malformations of individually named vessels (previously referred to as “truncular” malformations); the second groups lesions of uncertain or debated nature (tumor versus malformation). The known genetic defects underlying vascular anomalies are included in an appendix. This classification is meant to be a framework, acknowledging that it will require modification as new scientific information becomes available.
Skip Nav Destination
Article navigation
July 2015
Special Article|
July 01 2015
Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies
Michel Wassef, MD;
on behalf of the ISSVA Board and Scientific Committee
aAssistance Publique–Hopitaux de Paris, Lariboisière Hospital, Department of Pathology, Paris Diderot University, Paris, France;
Address correspondence to Michel Wassef, MD, Department of Pathology, Lariboisière Hospital, 2 rue Ambroise Paré, 75010 Paris, France. E-mail: [email protected]
Search for other works by this author on:
Francine Blei, MD;
on behalf of the ISSVA Board and Scientific Committee
Francine Blei, MD
bVascular Birthmark Program, Lenox Hill Hospital of North Shore Long Island Jewish Healthcare System, New York, New York;
Search for other works by this author on:
Denise Adams, MD;
on behalf of the ISSVA Board and Scientific Committee
Denise Adams, MD
cCincinnati Children's Hospital Medical Center, Cancer and Blood Disease Institute, University of Cincinnati, Cincinnati, Ohio;
Search for other works by this author on:
Ahmad Alomari, MD;
on behalf of the ISSVA Board and Scientific Committee
Ahmad Alomari, MD
dDepartment of Radiology, Boston Children’s Hospital and Harvard Medical School, Boston, Massachusetts;
Search for other works by this author on:
Eulalia Baselga, MD;
on behalf of the ISSVA Board and Scientific Committee
Eulalia Baselga, MD
ePediatric Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain;
Search for other works by this author on:
Alejandro Berenstein, MD;
on behalf of the ISSVA Board and Scientific Committee
Alejandro Berenstein, MD
fMt Sinai Healthcare System, Ichan School of Medicine, New York, New York;
Search for other works by this author on:
Patricia Burrows, MD;
on behalf of the ISSVA Board and Scientific Committee
Patricia Burrows, MD
gDepartment of Radiology, Medical College of Wisconsin, Milwaukee, Wisconsin;
Search for other works by this author on:
Ilona J. Frieden, MD;
on behalf of the ISSVA Board and Scientific Committee
Ilona J. Frieden, MD
hDepartment of Dermatology, University of California, San Francisco, San Francisco, California;
Search for other works by this author on:
Maria C. Garzon, MD;
on behalf of the ISSVA Board and Scientific Committee
Maria C. Garzon, MD
iDepartment of Dermatology, Columbia University, New York, New York;
Search for other works by this author on:
Juan-Carlos Lopez-Gutierrez, MD;
on behalf of the ISSVA Board and Scientific Committee
Juan-Carlos Lopez-Gutierrez, MD
jLa Paz Children´s Hospital, Madrid, Spain;
Search for other works by this author on:
David J.E. Lord, MD;
on behalf of the ISSVA Board and Scientific Committee
David J.E. Lord, MD
kInterventional Radiology, Sydney Children’s Hospitals Network, Sydney, Australia;
Search for other works by this author on:
Sally Mitchel, MD;
on behalf of the ISSVA Board and Scientific Committee
Sally Mitchel, MD
lDepartments of Radiology, Surgery, and Pediatrics, The Johns Hopkins Hospital, Baltimore, Maryland;
Search for other works by this author on:
Julie Powell, MD;
on behalf of the ISSVA Board and Scientific Committee
Julie Powell, MD
mDivision of Dermatology (Pediatrics), Centre Hospithalier Universitaire Sainte-Justine, University of Montreal, Montreal, Canada;
Search for other works by this author on:
Julie Prendiville, MD;
on behalf of the ISSVA Board and Scientific Committee
Julie Prendiville, MD
nPediatric Dermatology, University of British Columbia, Vancouver, Canada; and
Search for other works by this author on:
Miikka Vikkula, MD
on behalf of the ISSVA Board and Scientific Committee
Miikka Vikkula, MD
oLaboratory of Human Molecular Genetics, Christian de Duve Institute of Cellular Pathology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
Search for other works by this author on:
Address correspondence to Michel Wassef, MD, Department of Pathology, Lariboisière Hospital, 2 rue Ambroise Paré, 75010 Paris, France. E-mail: [email protected]
FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.
Pediatrics (2015) 136 (1): e203–e214.
Article history
Accepted:
March 27 2015
Citation
Michel Wassef, Francine Blei, Denise Adams, Ahmad Alomari, Eulalia Baselga, Alejandro Berenstein, Patricia Burrows, Ilona J. Frieden, Maria C. Garzon, Juan-Carlos Lopez-Gutierrez, David J.E. Lord, Sally Mitchel, Julie Powell, Julie Prendiville, Miikka Vikkula; on behalf of the ISSVA Board and Scientific Committee, Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies. Pediatrics July 2015; 136 (1): e203–e214. 10.1542/peds.2014-3673
Download citation file:
Sign in
Don't already have an account? Register
Purchased this content as a guest? Enter your email address to restore access.
Please enter valid email address.
Pay-Per-View Access
$35.00
Comments